Earnings Review · 19 November 2026
The print
Results are in but not yet verified against a primary source in our ledger; this review updates the moment the audited figures land. What does not change is our read below.
How the market took it
On 2026-11-19 the shares closed at $281.42, -1.7% against the prior close of $286.30 (opening +2.5% from the prior close). Sellers faded the pop: 4.2 points of the opening gain were given back by the close, which says the first read was too generous. Across the last 25 reports the shares have moved an average of +0.8% over the five sessions after the print, so the -1.7% on the day sits behind that average.
Did the flow confirm the move?
Underlying money flow reads as distribution (21-day Chaikin Money Flow -0.13, five-day price change -2.4%, as of 2026-11-17, desk flow model).
Give the business its due
The business itself is genuinely strong: revenue growing about 36%,
net margins near 19%, a moderate competitive moat, backed by a 21%
return on equity.
Levels that matter
At $281.42 the shares sit 28% below the 52-week high of $389.93 and 68% above the low of $167.23 (51% of the way up the range). The 50-day average is $333.21, above the price. The 200-day average is $321.12, above the price.
The valuation lens
Our fair-value work puts the shares about 28% below what the business is worth: value on offer. Fair value lands near $394 against a $281.42 share price, a margin of safety of about 28%. The trailing multiple sits around 39 times earnings, which only makes sense if the growth holds.
The
ethical lens, our differentiator
Screens compliant (both standards agree). A name values-conscious investors can weigh on the merits.
The verdict for a values-conscious investor
It clears the screen; size it to your own risk and conviction. One quarter, strong or soft, does not decide whether a holding is suitable.
This is analysis, not financial advice. Always manage your risk.